That's the number of specimens—including plants, animals, minerals, and human artifacts—curators estimate are held in the ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...

New York’s Commercial Division Rule 25-a, effective November 2025, promotes the use of the Virtual Evidence Courtroom (VEC), ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...

Every IT professional has sat through a vendor presentation where an incremental software update is pitched as a civilization-altering event. In late March 2026, the artificial intelligence industry ...

Amid growing opposition to data centers in Harford County, the County Council heard a presentation of a different tone on Tuesday. Although no data centers have yet been proposed in the county, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Lest you thought Microsoft would have all the fun introducing new AI features for white collar enterprise work this week with its Copilot Cowork announcement yesterday, Google is here to take back the ...

Presenting ten abstracts including observations on long-term safety, disease progression, and decline in muscle contractile area with givinostat Encore oral presentation also highlights analyses from ...

You can use Google’s generative AI tool to create slides, generate or edit images, refine text, and even create whole presentations. Here’s how. Gemini, Google’s generative AI assistant, has various ...

Twelve-month data from the VOLT-AF Global IDE study found that the Volt PFA System had an industry-leading success rate (84.2%) of freedom from documented rhythm recurrence among all competitive PFA ...

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...